Abstract
Recent decades have seen increases of overseas R&D operations, first in US multinational enterprises (MNEs) and later in those from Japan. Substantial parts of this growth have taken the form of laboratories, controlled by these MNEs, located in Europe.1 Furthermore European MNEs have a strongly-established commitment to the performance of R & D in Europe outside of their home country. This chapter argues that this growth of MNE R&D not only serves the obvious fundamental purpose of enhancing a firm’s competitiveness in the European market, but does so in a way that should be seen as also an integral part of the firm’s global strategy for sustained long-term development. In fact an argument of the chapter is that Europe can be seen as a middle level in the strategy of these firms, being perceived as a key region in the formulation of global strategy but also acknowledging the persistence of national needs and characteristics as potentially relevant to the effective implementation of European policies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.